# Mycapssa

NDC: 69880-120
Generic name: Octreotide
Labeler / Manufacturer: Amryt Pharmaceuticals Designated Activity Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20200706

FDA application: NDA208232

## Active ingredients

- OCTREOTIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69880-120"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69880-120
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=62a5e1eb-b48e-4ea6-8781-f75e490b17e4